Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas

Details for Australian Patent Application No. 2009201236 (hide)

Owner Wilex AG

Inventors Warnaar, Sven Ole; Ullrich, Stefan

Agent Davies Collison Cave

Pub. Number AU-B-2009201236

Parent 2003280442

Filing date 30 March 2009

Wipo publication date 23 April 2009

Acceptance publication date 26 May 2011

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

23 April 2009 Application Open to Public Inspection

  Published as AU-B-2009201236

23 April 2009 Complete Application Filed

26 May 2011 Application Accepted

  Published as AU-B-2009201236

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201237-Urinary incontinence device applicator

2009201235-A gaming system and method of gaming